AGP Picks
View all

Exploring the health and wellness news of Montserrat

Provided by AGP

Healthcare Focus Montserrat
Got News to Share?
Got News to Share? globe Explore more publications!

Healthcare Focus Montserrat: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Montserrat.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 18, 2026

Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures
May. 18, 2026

Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures

Indeterminate GlobeNewswire
Red Ribbon Recovery Indiana reports strong patient outcomes in first year of operation
May. 18, 2026

Red Ribbon Recovery Indiana reports strong patient outcomes in first year of operation

Indeterminate GlobeNewswire
Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer
May. 18, 2026

Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer

Indeterminate GlobeNewswire
American Kidney Fund Launches Clinical Education Curriculum for Healthcare Professionals
May. 18, 2026

American Kidney Fund Launches Clinical Education Curriculum for Healthcare Professionals

Indeterminate GlobeNewswire
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership for the Transformative Bio-Hermes-002 Study
May. 18, 2026

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership for the Transformative Bio-Hermes-002 Study

Indeterminate GlobeNewswire
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
May. 18, 2026

Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline

Indeterminate GlobeNewswire
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
May. 18, 2026

Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD

Indeterminate GlobeNewswire
GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
May. 18, 2026

GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase

Indeterminate GlobeNewswire
Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase
May. 18, 2026

Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase

Indeterminate GlobeNewswire
Parexel Launches ParexelAI™, Delivering AI Innovation to Accelerate Clinical Development
May. 18, 2026

Parexel Launches ParexelAI™, Delivering AI Innovation to Accelerate Clinical Development

Indeterminate GlobeNewswire
Aradigm Brings Cell and Gene Therapy Benefits Platform to Quantum Health’s Customers
May. 18, 2026

Aradigm Brings Cell and Gene Therapy Benefits Platform to Quantum Health’s Customers

Indeterminate GlobeNewswire
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
May. 18, 2026

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]

Indeterminate GlobeNewswire
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
May. 18, 2026

Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Indeterminate GlobeNewswire
Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study
May. 18, 2026

Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study

Indeterminate GlobeNewswire
Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications
May. 18, 2026

Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications

Indeterminate GlobeNewswire
SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion
May. 18, 2026

SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion

Indeterminate GlobeNewswire
Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
May. 18, 2026

Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution

Indeterminate GlobeNewswire
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May. 18, 2026

Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
May. 18, 2026

New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo

Indeterminate GlobeNewswire
FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics
May. 18, 2026

FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Healthcare Focus Montserrat

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.